Solution-phase submonomer diversification of aza-dipeptide building blocks and their application in aza-peptide and aza-DKP synthesis

Journal of Peptide Science

Volumn 16, Issue 6, 2010, Pages 284-296

  Bourguet, Carine B ^a   Proulx, Caroline ^a   Klocek, Sophie ^a   Sabatino, David ^a   Lubell, William D ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

turn conformation; Alkylation; Aza DKP; Aza Gly Xaa; Aza peptide; Benzophenone semicarbazone protecting group; DKP; Triazine

Indexed keywords

AZA DIKETOPIPERAZINE; AZA DIPEPTIDE; AZA PEPTIDE; BENZOPHENONE; DIPEPTIDE; HYDRAZONE DERIVATIVE; PEPTIDE; PIPERAZINE DERIVATIVE; SEMICARBAZONE; UNCLASSIFIED DRUG;

ALKYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; ENANTIOMER; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BENZOPHENONES; CARCINOGENS; DIPEPTIDES; HYDRAZINES; MOLECULAR STRUCTURE; SEMICARBAZONES;

EID: 77953474171     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1235     Document Type: Article

References (51)

1. Freidinger RM, Veber DF, Perlow DS, Brooks JR, Saperstein R. Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analog. Science 1980; 210: 656-658.
2. Hruby VJ. Conformational restrictions of biologically-active peptides via amino-acid side chain groups. Life Sci. 1982; 31: 189-199.
3. Rudinger J. In Drug Design, Vol. 2, Ariens J (ed). Academic: New York, 1971; 319-419.
4. Stigers KD, Soth MJ, Nowick JS. Designed molecules that fold to mimic protein secondary structures. Curr. Opin. Chem. Biol. 1999; 3: 714-723.
5. Gante J. Azapeptides. Synthesis 1989; 405-413.
6. Zega A. Azapeptides as pharmacological agents. Curr. Med. Chem. 2005; 12: 589-597.
7. Hess HJ, Moreland WT, Laubach GD. N-[2-Isopropyl-3-(L-aspartyl-L-arginyl) -carbazoyl]-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-phenylalanine. 1: an Isostere of Bovine Angiotensin II. J. Am. Chem. Soc. 1963; 85: 4040-4041.
8. Dutta AS, Furr BJA, Giles MB. Polypeptides. Part XV. Synthesis and biological-activity of alpha-aza-analogs of Luliberin modified in positions-6 and position-10. J. Chem. Soc. Perkin Trans. 1 1979; 379-388.
9. Ho TL, Nestor JJ, McCrae GI, Vickery BH. Hydrophobic, aza-glycine analogs of Luteinizing-hormone-releasing hormone. Int. J. Pept. Protein Res. 1984; 24: 79-84.
10. Lee HJ, Ahn IA, Ro S, Choi KH, Choi YS, Lee KB. Role of azaamino acid residue in beta-turn formation and stability in designed peptide. J. Pept. Res. 2000; 56: 35-46. (Pubitemid 30435436)
11. Lee HJ, Choi KH, Ahn IA, Ro S, Jang HG, Choi YS, Lee KB. The beta-turn preferential solution conformation of a tetrapeptide containing an azaamino acid residue. J. Mol. Struct. 2001; 569: 43-54. (Pubitemid 32660721)
12. Thormann M, Hofmann HJ. Conformational properties of azapeptides. J. Mol. Struct. THEOCHEM 1999; 469: 63-76.
13. Andre F, Boussard G, Bayeul D, Didierjean C, Aubry A, Marraud M. Aza-peptides. 2. X-ray structures of aza-alanine and aza-asparagine-containing peptides. J. Pept. Res. 1997; 49: 556-562. (Pubitemid 27335000)
14. Andre F, Vicherat A, Boussard G, Aubry A, Marraud M. Aza-peptides. 3. Experimental structural analysis of aza-alanine and aza-asparagine-containing peptides. J. Pept. Res. 1997; 50: 372-381. (Pubitemid 27469143)
15. Zouikri M, Vicherat A, Aubry A, Marraud M, Boussard G. Azaproline as a beta-turn-inducer residue opposed to proline. J. Pept. Res. 1998; 52: 19-26. (Pubitemid 28347603)
16. Cotton R, Gilles MB. Solid phase peptide synthesis, EP 0518655, 1993.
17. Lopez Areiza JJ, Rueckle T, Soto-Jara C. Aza-peptides, WO 2004/050689 A2, 2004.
18. Wang F, Ross J. Atazanavir: a novel azapeptide inhibitor of HIV-1 protease. Formulary 2003; 38: 691-702. (Pubitemid 37541764)
19. Calcagni A, Lucente G, Luisi G, Pinnen F, Rossi D, Gavuzzo E. Approaches to pseudopeptidic ergopeptines. 3. Consequences of the incorporation of an alpha-azaphenylalanine residue into the ergotamine oxa-cyclolic system. J. Chem. Soc. Perkin Trans. 1 1997; 2223-2227.
20. Andre F, Marraud M, Tsouloufis T, Tzartos SJ, Boussard G. Triphosgene: an efficient carbonylating agent for liquid and solidphase aza-peptide synthesis. Application to the synthesis of two aza-analogues of the AChR MIR decapeptide. J. Pept. Sci. 1997; 3: 429-441.
21. Melendez RE, Lubell WD. Aza-amino acid scan for rapid identification of secondary structure based on the application of N-Boc-aza-dipeptides in peptide synthesis. J. Am. Chem. Soc. 2004; 126: 6759-6764.
22. Boeglin D, Lubell WD. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with Fmoc chemistry and aza-amino acids with heteroatomic side chains. J. Comb. Chem. 2005; 7: 864-878.
23. Gibson C, Goodman SL, Hahn D, Holzemann G, Kessler H. Novel solid-phase synthesis of azapeptides and azapeptoides via Fmoc-strategy and its application in the synthesis of RGD-mimetics. J. Org. Chem. 1999; 64: 7388-7394.
24. Quibell M, Turnell WG, Johnson T. Synthesis of azapeptides by the Fmoc tert-butyl polyamide technique. J. Chem. Soc. Perkin Trans. 1 1993; 2843-2849.
25. Chong PY, Petillo PA. Solid phase urea synthesis: an efficient and direct conversion of Fmoc-protected amines to ureas. Tetrahedron Lett. 1999; 40: 4501-4504.
26. Limal D, Semetey V, Dalbon P, Jolivet M, Briand JP. Solid-phase synthesis of N,N′-unsymmetrically substituted ureas: application to the synthesis of carbaza peptides. Tetrahedron Lett. 1999; 40: 2749-2752.
27. Ragnarsson U. Synthetic methodology for alkyl substituted hydrazines. Chem. Soc. Rev. 2001; 30: 205-213.
28. Bourguet CB, Sabatino D, LubellWD. Benzophenone semicarbazone protection strategy for synthesis of aza-glycine containing azapeptides. Biopolymers 2008; 90: 824-831.
29. Sabatino D, Proulx C, Klocek S, Bourguet CB, Boeglin D, Ong H, Lubell WD. Exploring side-chain diversity by submonomer solid-phase aza-peptide synthesis. Org. Lett. 2009; 11: 3650-3653.
30. Brosse N, Pinto MF, Jamart-Gregoire B. New synthesis of 1,1-substituted hydrazines by alkylation of N-acyl- or N-alkyloxycarbonylaminophthalimide using the Mitsunobu protocol. J. Org. Chem. 2000; 65: 4370-4374.
31. Martins MB, Carvalho I. Diketopiperazines: biological activity and synthesis. Tetrahedron 2007; 63: 9923-9932.
32. Bouillon I, Brosse N, Vanderesse R, Jamart-Gregoire B. Liquid and solid phase syntheses of orthogonally protected alpha-hydrazinoacid derivatives. Tetrahedron Lett. 2004; 45: 3569-3572. (Pubitemid 38481728)
33. Brosse N, Pinto MF, Bodiguel J, Jamart-Gregoire B. A new synthetic route to protected alpha-hydrazinoesters in high optical purity using the Mitsunobu protocol. J. Org. Chem. 2001; 66: 2869-2873. (Pubitemid 32867712)
34. Brosse N, Pinto MF, Jamart-Gregoire B. N-tert- Butoxycarbonylaminophthalimide, a versatile reagent for the conversion of alcohols into alkylated tert-butylcarbazates or hydrazines via the Mitsunobu protocol. Tetrahedron Lett. 2000; 41: 205-207. (Pubitemid 30014602)
35. Brosse N, Pinto MF, Jamart-Gregoire B. Preparation of multiply protected alkylhydrazine derivatives by mitsunobu and PTC approaches. Eur. J. Org. Chem. 2003; 4757-4764.
36. Siu T, Yudin AK. Electrochemical imination of sulfoxides using N-aminophthalimide. Org. Lett. 2002; 4: 1839-1842.
37. Wieczerzak E, Drabik P, Lankiewicz L, Oldziej S, Grzonka Z, Abrahamson M, Grubb A, Bromme D. Aza-peptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. J.Med. Chem. 2002; 45: 4202-4211.
38. O'Donnell MJ. The enantioselective synthesis of alpha-amino acids by phase-transfer catalysiswith achiral Schiff base esters. Acc. Chem. Res. 2004; 37: 506-517.
39. O'Donnell MJ, Bennett WD, Bruder WA, Jacobsen WN, Knuth K, Leclef B, Polt RL, Bordwell FG, Mrozack SR, Cripe TA. Acidities of glycine schiff-bases and alkylation of their conjugate bases. J. Am. Chem. Soc. 1988; 110: 8520-8525.
40. Goodman M, Felix A, Moroder L, Toniolo C (eds.). Methods of Organic Chemistry: Synthesis of Peptides and Peptidomimetics. Stuttgart, New York: Thieme (Houben-Weyl): 2001; 227-228.
41. Anderson GW, Callahan FM. t-Butyl esters of amino acids and peptides and their use in peptide synthesis. J. Am. Chem. Soc. 1960; 82: 3359-3363.
42. 2O-NaI system in acetonitrile. J. Org. Chem. 2001; 66: 4430-4432.
43. 2 in methylene chloride. Tetrahedron Lett. 2000; 41: 2847-2849.
44. Obreza A, Urleb U. A two-step synthesis of hexahydropyrrolo[1,2-d][1,2,4] triazine-1,4-dione and related compounds. Synth. Commun. 2003; 33: 1011-1018. (Pubitemid 36458748)
45. Pinnen F, Luisi G, Lucente G, Gavuzzo E, Cerrini S. Approaches to pseudopeptidic ergopeptines-Synthesis and molecular-structure of an alpha-aza-phenylalanine-containing oxa-cyclol. J. Chem. Soc. Perkin Trans. 1 1993; 819-824.
46. Dutta AS, Morley JS. Polypeptides. Part XIII. Preparation of alpha-aza-amino-acid (carbazic acid) derivatives and intermediates for the preparation of alpha-aza-peptides. J. Chem. Soc. Perkin Trans. I 1975; 1712-1720.
47. Asano N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 2003; 13: 93R-104R. (Pubitemid 37337046)
48. Sinha S, Srivastava R, De Clereq E, Singh RK. Synthesis and antiviral properties of arabino and ribonucleosides of 1,3-dideazaadenine, 4-nitro-1,3-dideazapurine and diketopiperazine. Nucleosides Nucleotides Nucleic Acids 2004; 23: 1815-1824. (Pubitemid 39657365)
49. Cheung M, Harris PA, Badiang JG, Peckham GE, Chamberlain SD, Alberti MJ, Jung DK, Harris SS, Bramson NH, Epperly AH, Stimpson SA, Peel MR. The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors. Bioorg. Med. Chem. Lett. 2008; 18: 5428-5430.
50. Constable EC. 2,2′:6′,2″-Terpyridines: from chemical obscurity to common supramolecularmotifs. Chem. Soc. Rev. 2007; 36: 246-253.
51. Gehre A, Stanforth SP,Tarbit B.Aconvenient synthesisof substituted 2,2′:6′,2″-terpyridines. Tetrahedron 2009; 65: 1115-1118.